EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GLUT9b- and ABCG2-mediated collecting duct urate transport uncovers a vasopressin-independent mechanism of renal water reabsorption

Mohamad Hadla, Jean Marc Mardirossian, Daniel G Bichet, Abdul Hamid Borghol, Georges Abboud, Ahmad Ghanem, Eduardo Chini, Peter Harris, Vicente E Torres, Seth L Alper, Volker Vallon, Fouad T Chebib

Journal of Clinical Investigation · 2026

DOI: 10.1172/jci197021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Mohamad Hadla und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida, USA. Hauptthemen laut MEDLINE: Kidney Tubules, Collecting, Uric Acid, Renal Reabsorption, ATP Binding Cassette Transporter, Subfamily G, Member 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Otsuka America, NIDDK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal water reabsorption is classically regulated by vasopressin V2 receptor (V2R) signaling through cyclic AMP and protein kinase A, driving apical accumulation of aquaporin-2 (AQP2). However, collecting duct water handling is also modulated by vasopressin-independent mechanisms. Here, we examined intracellular soluble urate as a vasopressin-independent regulator of AQP2 trafficking. Intracellular urate accumulation in collecting duct cells was mediated by enhanced apical urate uptake via GLUT9b and reduced apical urate efflux through ABCG2, triggering phosphodiesterase-4 activation, reduced cAMP, and downstream AMP-activated protein kinase (AMPK) activation. The resulting AQP2 accumulation at the apical membrane was independent of V2R signaling, required ongoing endocytosis, and was associated with features of postendocytic apical trafficking of internalized AQP2. In vivo ABCG2 inhibition with probenecid increased apical AQP2 abundance and markedly attenuated tolvaptan-induced polyuria in both wild-type and Pkd1 RC/RC autosomal dominant polycystic kidney disease (ADPKD) mice in a uricase-independent manner while preserving tolvaptan’s ADPKD-modifying efficacy. In a phase II trial with tolvaptan-treated patients with ADPKD, probenecid reduced urine volume and nocturia frequency. Together, these findings support a vasopressin-independent urate/AMPK/AQP2 pathway that regulates renal water handling and, in a preclinical ADPKD model, can uncouple cyst growth attenuation from the dose-limiting aquaretic effects of V2R antagonism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney Tubules, CollectingUric AcidRenal ReabsorptionATP Binding Cassette Transporter, Subfamily G, Member 2Glucose Transport Proteins, FacilitativeVasopressinsNeoplasm ProteinsWaterAnimalsAquaporin 2MiceMice, KnockoutReceptors, VasopressinHumansMaleSignal Transduction

Stichwörter der Autor:innen

Cell biologyClinical trialsEpithelial transport of ions and waterGenetic diseasesNephrology

Substanzen

Aquaporin 2Uric AcidATP Binding Cassette Transporter, Subfamily G, Member 2Aqp2 protein, mouseGlucose Transport Proteins, FacilitativeVasopressinsAbcg2 protein, mouseNeoplasm ProteinsReceptors, VasopressinWater

Autor:innen und Institutionen

  • Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida, USA.
  • Departments of Medicine and of Pharmacology and Physiology, University of Montreal, Montreal, Quebec, Canada.
  • Nephrology Service, Hôpital du Sacré-Cœur de Montréal, Montreal, Quebec, Canada.
  • Metabolism and Molecular Nutrition Laboratory, Kogod Center on Aging, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine, Jacksonville, Florida, USA.
  • Division of Nephrology and Hypertension and.
  • Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA.

Förderung

  • NIDDK NIH HHS
  • Otsuka America
  • NIDDK

Zitieren

APA

Hadla, M., Mardirossian, J. M., Bichet, D. G., Borghol, A. H., Abboud, G., Ghanem, A., Chini, E., Harris, P., Torres, V. E., Alper, S. L., Vallon, V., & Chebib, F. T. (2026). GLUT9b- and ABCG2-mediated collecting duct urate transport uncovers a vasopressin-independent mechanism of renal water reabsorption. Journal of Clinical Investigation. https://doi.org/10.1172/jci197021

Vancouver

Hadla M, Mardirossian JM, Bichet DG, Borghol AH, Abboud G, Ghanem A, et al. GLUT9b- and ABCG2-mediated collecting duct urate transport uncovers a vasopressin-independent mechanism of renal water reabsorption. Journal of Clinical Investigation. 2026. doi:10.1172/jci197021

BibTeX
@article{Hadla2026,
  author = {Hadla, Mohamad and Mardirossian, Jean Marc and Bichet, Daniel G and Borghol, Abdul Hamid and Abboud, Georges and Ghanem, Ahmad and Chini, Eduardo and Harris, Peter and Torres, Vicente E and Alper, Seth L and Vallon, Volker and Chebib, Fouad T},
  title = {GLUT9b- and ABCG2-mediated collecting duct urate transport uncovers a vasopressin-independent mechanism of renal water reabsorption},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1172/jci197021}
}
Kostenlos starten →